Scienture Holdings (SCNX) Research & Development (2025 - 2026)
Scienture Holdings (SCNX) posted Research & Development of $793984.0 for Q1 2026, down 5.88% sequentially from $843549.0 in Q2 2025, and up 38.16% YoY from $574679.0 in Q1 2025.
Scienture Holdings (SCNX) Research & Development (2025 - 2026) Analysis & Trends
Scienture Holdings has reported Research & Development for 2 years, with the latest figure at $793984.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | High Tide | 215.72 Mn | 182.44 Mn | 35.30 Mn | - |
| 2 | BioScience Health Innovations | 46.85 Mn | 46.14 Mn | 659,483.00 | - |
| 3 | Petmed Express | 38.27 Mn | 25.17 Mn | 11.33 Mn | - |
| 4 | Scienture Holdings | 18.71 Mn | 18.71 Mn | 335,779.00 | 1.17 Mn |
| 5 | Polomar Health Services | 8.48 Mn | 8.31 Mn | 935,916.00 | 456,419.00 |
| 6 | Ridgetech | 58,250.67 | -17.85 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.17 Mn |
| Mar 31, 2026 | 793,984.00 |
| Jun 30, 2025 | 843,549.00 |
| Mar 31, 2025 | 574,679.00 |